{"gao_id": "GAO-22-105733", "published": "2022-02-17T12:00:00Z", "released": "2022-02-17T07:00:00Z", "summary": "The 2018 National Biodefense Strategy outlines how the U.S. can prepare for and respond to biological threats, such as COVID-19. The pandemic highlighted shortcomings in federal response efforts. For example, federal agencies had problems managing information\u2014like inconsistent federal guidance and lack of transparency about available supplies in the strategic national stockpile. We testified on our decades-long work evaluating federal agencies' biodefense efforts and preparedness, as...", "title": "Biodefense: Opportunities to Address National Strategy and Programmatic Challenges", "topics": ["Federal agencies", "National defense", "Biological weapons", "Health care", "pandemics", "Homeland Security", "Strategic plan", "Biosurveillance", "Biological warfare", "Public and private partnerships", "Homeland security", "Bioterrorism"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-22-105733", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-22-105733-highlights.pdf"}, {"title": "Full Report (16 pages)", "url": "https://www.gao.gov/assets/gao-22-105733.pdf"}, {"title": "Accessible PDF (18 pages)", "url": "https://www.gao.gov/assets/720/719119.pdf"}]}